3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
4
Gynecologic
2
Sarcoma
1
Conditions
Endometrial Neoplasms
13
Uterine Cervical Neoplasms
4
Ovarian Neoplasms
3
Vulvar Neoplasms
2
Squamous Intraepithelial Lesions
2
Rectal Neoplasms
2
Peritoneal Neoplasms
2
Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Anus Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sezary Syndrome
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Interventions
Cyclophosphamide
8
pembrolizumab
7
fludarabine
6
aldesleukin
4
Papillomavirus Vaccines
4
Vaccines
3
Radiotherapy
3
Light Coagulation
3
Biopsy
3
spartalizumab
2
fludarabine phosphate
2
entinostat
2
Watchful Waiting
2
Vorinostat
2
VGX-3100
2
Trastuzumab
2
Tomography, X-Ray Computed
2
Surveys and Questionnaires
2
Paclitaxel
2
Observation
2
Nivolumab
2
Interleukin-2
2
Interleukin-12 Subunit p35
2
Early Intervention, Educational
2
Drug Therapy
2
Carboplatin
2
Adoptive Transfer
2
trastuzumab deruxtecan
1
tislelizumab
1
tipifarnib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
Observation
×
Gynecologic
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts
NCT02503111
2022-06-13
HPV-SAVE
University Health Network, Toronto
Phase NA
Terminated
71 enrolled